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ABSTRACT
Expression of nucleotide-binding oligomerization domain protein 2 (NOD2) is 
upregulated in pulmonary artery smooth muscle cells (PASMCs) during hypoxia. To 
investigate the involvement of NOD2 in the pulmonary vascular response to hypoxia, 
we subjected wild-type and NOD2-deficient mice to chronic normobaric hypoxic 
conditions. Compared to wild-type mice, NOD2-deficient mice developed severe 
pulmonary hypertension with exaggerated elevation of right ventricular systolic 
pressure, profound right ventricular hypertrophy and striking vascular remodeling 
after exposure to hypoxia. Pulmonary vascular remodeling in NOD2-deficient mice 
was characterized by increased PASMC proliferation. Furthermore, hypoxia-inducible 
factor-1α expression and Akt phosphorylation were upregulated in PASMCs from 
NOD2-deficient mice exposed to hypoxia. Our findings revealed that the absence of 
NOD2 exacerbated hypoxia-induced PASMC proliferation, pulmonary hypertension 
and vascular remodeling, but had no effect on PASMC migration or contractility.
INTRODUCTION
Pulmonary hypertension (PH) commonly occurs in 
populations that live at high altitudes and in individuals who 
experience chronic hypoxia due to pulmonary conditions. In 
people with chronic obstructive pulmonary disease, PH can 
cause the right side of the heart to fail, resulting in fatality 
[1–3]. The walls of pulmonary blood vessels can undergo 
cellular and histological alterations due to sustained 
hypoxia. The remodeling of pulmonary blood vessels 
is characterized by increases in pulmonary vessel wall 
thickness and small artery muscularization. In vivo studies 
have indicated that hypoxia increases the wall thickness 
of pulmonary blood vessels by promoting pulmonary 
artery smooth muscle cell (PASMC) proliferation [4, 5]. 
Additionally, pulmonary vascular cells have been reported 
to proliferate in response to hypoxia in vitro [6–8].
Hypoxia activates phosphatidylinositol 3-kinase 
(PI3K) signal transduction, which leads to the 
phosphorylation of the serine/threonine kinase Akt. While 
the induction of PI3K and Akt signaling is important 
for cells to grow, proliferate, migrate and survive [9], 
this pathway can also stimulate cellular proliferation in 
response to hypoxia. Indeed, Akt activation has been 
observed during the remodeling of blood vessels and the 
proliferation of PASMCs following vascular injury and 
hypoxia [10], and has been reported to stabilize hypoxia-
inducible factor-1 alpha (HIF-1α) [11]. Notably, HIF-1 
and HIF-2 are important transcriptional regulators in 
response to hypoxia. The transcription factor HIF-1 is 
a heterodimer: α-subunit (HIF-1α) expression depends 
on oxygen levels, while β-subunit (HIF-1β/ARNT) 
expression is constitutive [12]. During normoxia, the 
degradation of HIF-1α is initiated by the hydroxylation of 
conserved proline residues [13]. However, during hypoxia, 
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this process is inhibited, such that HIF-1α accumulates, 
dimerizes with HIF-1β and induces hypoxia-specific gene 
expression [14]. Recently, the development of pulmonary 
arterial hypertension was linked to HIF signaling [5, 6, 8, 
15]. The hypoxia-induced proliferation of smooth muscle 
cells is inhibited by HIF-1α knockdown [13], suggesting 
that HIF-1α contributes to the remodeling of pulmonary 
blood vessels and the elevation of right ventricular systolic 
pressure (RVSP) when PASMCs are exposed to chronic 
hypoxia. 
The nucleotide-binding oligomerization domain 
protein 2 (NOD2) gene has been reported to determine 
whether individuals will be vulnerable to inflammatory 
bowel diseases and Crohn’s disease [16, 17]. This gene 
encodes an intracellular protein that resembles the Toll-
like receptors (TLRs) in its leucine-rich repeats. Through 
its binding to muramyl dipeptide, NOD2 functions 
intracellularly as a pathogen recognition receptor (PRR) 
that recognizes the peptidoglycans of gram-positive and 
-negative bacteria [18]. NOD2 is expressed in myeloid 
cells such as neutrophils, macrophages and dendritic cells, 
and in small intestinal Paneth cells [19, 20]. However, 
NOD2 has been reported to be expressed or to perform 
different activities in cells such as vascular endothelial 
cells, gingival and pulp fibroblasts, adipocytes and 
vascular smooth muscle cells (VSMCs) [21–26].
The function of NOD2 in systemic arterial VSMCs 
has been published, but its function in VSMCs of the 
pulmonary circulatory system (including the remodeling 
of pulmonary blood vessels) has been underexplored. 
Previously, we demonstrated that arterial VSMCs 
expressed functional NOD2, but were stimulated to 
proliferate, migrate and form neointima in a NOD2-
deficient animal model [26]. Here, we evaluated the 
effects of NOD2 on HIF-1α and Akt signaling, pulmonary 
vascular remodeling and PASMC proliferation in response 
to hypoxia.
RESULTS
NOD2 deficiency increases RVSP and induces 
right ventricular hypertrophy following chronic 
hypoxia
We first investigated the involvement of NOD2 in 
the pulmonary reaction to hypoxic conditions by analyzing 
the mRNA expression of Nod2 within mouse lungs. Nod2 
expression has been reported in many different cell types, 
including systemic arterial VSMCs [26]. VSMCs are also 
very important in the pulmonary circulatory system, and 
perform a number of tasks that are critical for pulmonary 
function. However, the contribution of NOD2 to lung 
disease has yet to be reported. We compared the mRNA 
levels of Nod2 in the lungs of wild-type mice with those in 
bone marrow-derived macrophages (BMDMs) stimulated 
with LPS and IFN-gamma to induce Nod2 expression 
(a positive control) (Supplementary Figure 1). Notably, 
the basal level of Nod2 expression was 12-fold higher in 
mouse lungs than in BMDMs. 
Hypoxia is a well-known stimulus of PH, and can 
occur in individuals with extensive damage of the lung 
parenchyma due to chronic lung conditions [27]. Hence, 
we investigated whether hypoxia stimulates the expression 
of Nod2. We extracted total RNA from NOD2+/+ mouse 
lungs after exposing them to normoxic or hypoxic 
conditions for two weeks. As shown in Figure 1A and 1B, 
the mRNA levels of Nod2 and Nod1 in the lungs were 
greater in mice subjected to hypoxia than in those exposed 
to normoxia. However, there were no differences between 
the two groups in Tlr2, Tlr4, Hif-1α or Hif-1β mRNA 
levels after two weeks (Figure 1C–1F). 
Next, we subjected NOD2−/− and NOD2+/+ mice 
to normoxic or normobaric hypoxic conditions for two 
weeks. We then assessed whether the pulmonary arteries 
were becoming hypertensive by determining the RVSP and 
Fulton’s index (the ratio of the right ventricular mass to the 
sum of the left ventricular and septal masses), a measure 
of hypertrophy in the right ventricle due to elevated right 
ventricular pressure and afterload. Following hypoxic 
treatment, the RVSP was significantly higher in NOD2−/− 
mice (30.13 ± 0.9 mmHg) than in NOD2+/+ mice (23.6 
± 1.3 mmHg; P < 0.05) and normoxic mice (Figure 
2A). Additionally, Fulton’s index values were higher in 
NOD2−/− mice than in NOD2+/+ mice (0.37 ± 0.002 vs. 0.29 
± 0.003, P < 0.05) after normobaric hypoxic treatment 
(Figure 2B). However, the total body weights and whole 
heart weights did not differ between NOD2−/− (21.59 ± 
0.4 g and 111.53 ± 3.4 mg, respectively) and NOD2+/+ 
(20.27 ± 0.75 g and 122.12 ± 5.6 mg, respectively) mice 
after exposure to normobaric hypoxic conditions (Figure 
2C and 2D). Our results indicate that increased NOD2 
levels improve the reaction of pulmonary blood vessels to 
hypoxic conditions. 
Absence of NOD2 promotes the remodeling of 
pulmonary blood vessels and the hypertrophy of PASMCs 
following chronic hypoxia.
We then performed histology to investigate the 
effects of NOD2 expression on the remodeling of 
pulmonary blood vessels during PH caused by hypoxia. 
Staining with hematoxylin and eosin demonstrated that 
the blood vessels were remodeled to a greater extent 
in NOD2−/− mice than in NOD2+/+ mice after hypoxic 
treatment (Figure 3A). Moreover, under hypoxic 
conditions, the thickness of the pulmonary arteriole walls 
increased further in NOD2−/− mice (64.19 ± 6.8%) than 
in NOD2+/+ mice (38.85 ± 3.6%; P < 0.05) or normoxic 
controls (Figure 3B). 
To determine whether the enhanced pulmonary 
vascular remodeling after normobaric hypoxia involved 
PASMC hypertrophy, we analyzed the prevalence of alpha-
smooth muscle actin (α-SMA)-positive cells in the lungs of 
NOD2−/− and NOD2+/+ mice. In both NOD2−/− and NOD2+/+ 
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mice, little collagen was deposited in the distal blood vessels 
that had undergone remodeling (Trichrome staining; data 
not shown). On the other hand, α-SMA immunostaining 
indicated that the blood vessels of NOD2−/− mice were 
profoundly remodeled in response to hypoxic conditions; 
the distal pulmonary arterioles were neomuscularized, 
exhibiting neointimal enlargement and α-SMA-positivity 
(Figure 4A). Conversely, the vessels of NOD2+/+ mice were 
remodeled to a significantly lesser degree and harbored 
fewer α-SMA-positive cells. Morphometric analysis 
revealed significant PASMC hypertrophy after hypoxia in 
NOD2−/− mice, corresponding to a significantly greater area 
per cell (1540 ± 98 pixels) than their NOD2+/+ counterparts 
(950 ± 158 pixels) (Figure 4B). 
Subsequently, we performed Western blotting to 
quantify the amount of α-SMA protein in the lungs of 
NOD2−/− and NOD2+/+ mice after exposing them to hypoxic 
and normoxic conditions (Figure 4C). Interestingly, the 
baseline levels of α-SMA protein were slightly higher 
in NOD2−/− mice than in NOD2+/+ mice. After hypoxia, 
however, α-SMA protein expression increased an 
additional 4.5-fold in NOD2−/− lungs, significantly greater 
than the 2.2-fold upregulation observed in NOD2+/+ lungs 
(Figure 4D). Thus, NOD2 may confer protective effects 
with respect to pulmonary vascular remodeling and 
PASMC hypertrophy after hypoxia. 
Enhanced PASMC proliferation contributes to 
the hypoxic vascular remodeling of the NOD2−/− 
strain 
We next investigated the function of NOD2 in 
vitro by subjecting PASMCs to hypoxic conditions and 
analyzing Nod2 mRNA expression. While Nod2 mRNA 
levels began to increase in PASMCs 6 hours after the cells 
were exposed to hypoxia, this increase was much more 
striking after 48 hours (Figure 5A). 
To elucidate the potential mechanisms whereby 
NOD2 influences pulmonary vascular remodeling, we 
investigated the proliferation, migration and contractility 
of NOD2−/− PASMCs exposed to hypoxia in vitro. The 
proliferation of NOD2−/− PASMCs was 2.23 ± 0.42-fold 
greater than that of NOD2+/+ PASMCs under hypoxic 
conditions (Figure 5B). We subsequently used gelatin-
coated 24-Transwell chambers to assess the effect of 
NOD2 on cellular migration. Notably, the migration of 
NOD2−/− and NOD2+/+ PASMCs did not differ significantly 
(132.97 ± 4.2 cells/mm2 and 92.64 ± 5.7 cells/mm2, 
respectively) in response to hypoxia (Supplementary 
Figure 2A and 2B). Next, we investigated cell contractility 
using a three-dimensional collagen matrix assay. Hypoxic 
NOD2−/− and NOD2+/+ PASMCs exhibited similar levels 
of gel contraction 4 hours after matrix release (64 ± 
Figure 1: Nod2 expression is enhanced in the mouse lung after chronic hypoxia. -Total RNA was extracted from NOD2+/+ 
lungs after two weeks of exposure to normoxic (21% O2) or normobaric hypoxic (10% O2) conditions. Quantitative real-time RT-PCR was 
performed to compare the mRNA levels of Nod2 (A), Nod1 (B), Tlr2 (C), Tlr4 (D), Hif-1α (E) and Hif-1β (F) between the groups. *P < 0.05, 
upregulation of mRNA levels in the hypoxia vs. normoxia group. For all real-time PCR analyses, mouse β-actin was used as a control for 
normalization. The expression of each mRNA was normalized to that of β-actin. Values are presented as means ± SDs, n = 3. 
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3.0% and 56 ± 3.3% of original gel size, respectively) 
(Supplementary Figure 2C and 2D). 
To determine the molecular pathways that induced 
the growth of NOD2-deficient PASMCs, we investigated 
the effects of NOD2 deficiency on PI3K and Akt signaling 
under hypoxic conditions. For these experiments, total 
protein was harvested from NOD2+/+ and NOD2−/− 
PASMCs at 0.25, 0.5, 1, 2, 3 and 6 hours after hypoxic 
treatment. Assessment of the mitogen-activated 
protein kinase pathway revealed that phosphorylated 
extracellular signal-regulated kinase (pERK) levels 
in NOD2−/− PASMCs were not altered compared with 
NOD2+/+ PASMCs after hypoxia. Also, p-p38 and stress-
activated protein kinase/c-Jun NH2-terminal kinase 
(SAPK/JNK) were not detected in response to hypoxia 
(data not shown). In contrast, Akt phosphorylation (i.e., 
activation) was enhanced in NOD2−/− PASMCs exposed 
to hypoxic conditions compare with NOD2+/+ PASMCs 
(Figure 5C). 
HIF-1α is another important mediator of arterial 
remodeling and PH in response to chronic hypoxia [15]. 
To investigate the effects of NOD2 deficiency on HIF-
1α expression, we harvested total RNA and protein from 
NOD2+/+ and NOD2−/− PASMCs exposed to hypoxia for 6, 
12, 24, 48 and 72 hours. HIF-1α protein was maintained 
until 24 hours post-exposure and then it was decreased 
in NOD2+/+ PASMCs. On the other hand, an increase in 
the expression of this protein was observed in NOD2−/− 
PASMCs by 12 hours after hypoxia exposure, and a more 
striking increase was evident after 48 hours (Figure 6A). 
Furthermore, in NOD2−/− PASMCs, we observed reduced 
protein expression of hydroxyl-HIF-1α (Pro564) and prolyl 
hydroxylase domain protein 2 (PHD2), which facilitates 
the attachment of HIF-1α to the von Hippel-Lindau 
Figure 2: Exaggerated elevation of RVSP and Fulton’s index values in NOD2−/− mice after chronic hypoxia. (A) RVSP 
in NOD2+/+ (black bars) and NOD2−/− (white bars) mice after two-week exposure to hypoxic (n = 18 per group) or normoxic (n = 10 per 
group) conditions. (B) Fulton’s index values (ratio of right ventricular weight to left ventricular plus septal weight) of NOD2+/+ (black bars) 
and NOD2−/− (white bars) mice after two-week exposure to hypoxic (n = 18 per group) or normoxic (n = 15 per group) conditions. C and 
D, The body weights (C) and whole heart weights (D) of NOD2+/+ (black bars) and NOD2−/− (white bars) mice after exposure to hypoxic 
(n = 18 per group) or normoxic (n = 15 per group) conditions for two weeks. Data are expressed as means ± SDs; *P < 0.05 for hypoxic 
NOD2−/− mice vs. hypoxic NOD2+/+ mice. 
Oncotarget12675www.impactjournals.com/oncotarget
(VHL) E3 ubiquitin ligase and its subsequent ubiquitin-
dependent degradation [13, 28]. Overall, however, there 
were no changes in HIF-1β and HIF-2α protein expression. 
Interestingly, increased VHL protein expression was 
detected in NOD2−/− PASMCs. Lastly, we observed a time-
dependent increase in Hif-1α, Hif-1β and Hif-2α mRNA 
levels in both NOD2+/+ and NOD2−/− PASMCs upon 
exposure to hypoxic conditions; however, the expression of 
these factors did not differ between NOD2+/+ and NOD2−/− 
PASMCs after hypoxia exposure (Figure 6B–6D).
Together, our data indicate that greater PASMC 
proliferation, not migration or contractility, is responsible 
for the remodeling of pulmonary blood vessels in 
hypoxia-exposed NOD2−/− mice. Moreover, prolonged 
Akt phosphorylation and HIF-1α expression are important 
contributors to the enhanced proliferation of NOD2−/− 
PASMCs during hypoxia.
DISCUSSION
TLRs, which comprise a class of transmembrane 
PRR, were suggested to connect inflammation with PH, 
thus contributing to the emergence of PH, while being 
dispensable for lesion formation [29–31]. TLR signaling, 
especially involving TLR2 and 4, has been described 
in human pulmonary vascular cells and patients with 
idiopathic pulmonary arterial hypertension [29–32]. 
Moreover, the TLR Pro631His variant correlates robustly 
with PH incidence in patients with systemic sclerosis 
[30]. Conversely, other studies have suggested that 
NOD2 and TLR3 have protective functions in vascular 
diseases, including atherosclerosis [26, 33]; indeed, we 
previously demonstrated such a function of NOD2 in 
arterial VSMCs. Mouse arterial VSMC proliferation and 
migration were associated negatively with the induction of 
NOD2 expression, and NOD2-deficient arterial VSMCs 
proliferated, migrated and formed neointima following 
vascular damage [26]. Using a perivascular collar model, 
Cole et al. demonstrated that activated TLR3 suppressed 
the development of the neointima following carotid 
damage. In contrast, atherosclerotic lesions in the aortic 
root formed earlier in TLR3/apolipoprotein E double-
knockout mice (ApoE−/−/TLR3−/−) than in control mice 
(ApoE+/+/TLR3+/+). Considered along with the models of 
vascular damage, these results indicate that PRRs like 
NOD2 and TLR3 may not merely be innate immune 
receptors, but also have other functions. While PRRs 
are necessary for innate immunity, they may perform 
markedly different activities in response to noninfectious 
stimuli. As an example, PRRs such as TLR3 and NOD2 
protect the walls of the blood vessels, while others such 
as TLR2 and TLR4 can damage them. We hypothesized 
that NOD2 may also have a protective function during 
hypoxia, preventing an exaggerated increase in pulmonary 
vascular remodeling and RVSP.
Consistent with this hypothesis, we observed 
enhanced Nod2 expression in the lungs following 
prolonged exposure of mice to hypoxic conditions (Figure 
1A). Interestingly, the RVSP and Fulton’s index values 
were significantly greater in NOD2-deficient mice than 
in wild-type mice after chronic hypoxic treatment (Figure 
2A and 2B). We subsequently assessed pulmonary arterial 
remodeling after two weeks of normobaric hypoxic (10% 
O2) treatment to determine whether the observed changes 
Figure 3: NOD2 deficiency enhances pulmonary vascular remodeling after chronic hypoxia. (A) Representative 5-μm 
hematoxylin and eosin-stained sections from NOD2+/+ (left) and NOD2−/− (right) mice, generated after two weeks of normoxic (top) or 
hypoxic (bottom) treatment. (B) Quantification of pulmonary arteriole wall thickness within the lungs of NOD2+/+ (black bars) and NOD2−/− 
(white bars) mice after exposure to normoxic (n = 7 per group) or hypoxic (n = 10 per group) conditions for two weeks (values expressed as 
percentages). Ten vessels were analyzed per mouse. Data are expressed as means ± SDs; *P < 0.05 for hypoxic NOD2−/− mice vs. hypoxic 
NOD2+/+ mice.
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in the RVSP and Fulton’s index values were associated 
with PH. Following two weeks of chronic hypoxia, the 
medial layer of small pulmonary arteries exhibited greater 
thickening in NOD2−/− mice than in NOD2+/+ mice (Figure 
3A). In addition, the PASMCs of NOD2-deficient mice 
became significantly hypertrophic, contributing to the 
striking remodeling of the blood vessels (Figure 4A and 
4B). Interestingly, while baseline expression of α-SMA 
was greater in NOD2−/− mice than in NOD2+/+ mice, the 
RVSP and Fulton’s index values did not differ significantly 
between ten- to twelve-week-old NOD2+/+ and NOD2−/− 
mice exposed to normoxic conditions. Thus, in the 
absence of vascular remodeling (Figure 3), the source 
of α-SMA does not appear to be the VSMCs of small 
pulmonary vessels. In older mice, however, enhanced 
α-SMA expression might alter the RVSP or Fulton’s index 
of NOD2−/− mice under normoxic conditions.
In animals, hypoxia stimulates the proliferation 
of PASMCs, thus increasing the wall thickness of the 
pulmonary blood vessels [4, 5]. The pathologic process 
whereby pulmonary blood vessels are remodeled 
intensifies as PASMCs proliferate increasingly. Here, we 
used mouse primary PASMCs to study the involvement of 
NOD2 in PASMC proliferation in response to hypoxia. In 
general, hypoxia promoted Nod2 expression in PASMCs; 
however, NOD2−/− PASMCs proliferated at a higher level 
than NOD2+/+ PASMCs under hypoxic conditions (Figure 
5A and 5B). While PASMC migration and contractility are 
also involved in the pathogenesis of pulmonary vascular 
remodeling [1, 34], the migratory and contractility 
capacities of NOD2−/− and NOD2+/+ PASMCs did not differ 
significantly after hypoxic treatment (Supplementary 
Figure 2). These results suggest that NOD2 protects 
against pulmonary vascular remodeling under hypoxic 
conditions by preventing PASMC proliferation. 
Generally, hypoxia initiates PI3K signaling, 
which leads to Akt phosphorylation [9, 10]. These 
pathways, along with the HIF signaling pathway, are 
thought to contribute to the proliferation of PASMCs 
under hypoxic conditions. Muramyl dipeptide, a ligand 
recognized by NOD2, independently induces Akt 
phosphorylation in different cell types [35, 36], but 
Figure 4: NOD2−/− mice exhibit enhanced hypertrophy of PASMCs after hypoxia. (A) α-SMA immunostaining of the lungs of 
NOD2+/+ (left) and NOD2−/− (right) mice after exposure to normoxic (top) or hypoxic (bottom) conditions for two weeks. (B) Quantification 
of PASMC size in NOD2+/+ (black bars) and NOD2−/− (white bars) mice. Ten vessels per mouse were analyzed after exposure to normoxic 
(n = 5 per group) or hypoxic (n = 8 per group) conditions for two weeks. Data are expressed as means ± SDs; *P < 0.05 for hypoxic 
NOD2−/− mice vs. hypoxic NOD2+/+ mice. (C) Western blot analysis of α-SMA levels in the lungs of NOD2+/+ and NOD2−/− mice after two 
weeks of exposure to hypoxic or normoxic conditions. GAPDH was used as control for normalization. The experiment was conducted three 
times, and the images depict representative results. (D) Normalized α-SMA levels represented graphically. *P < 0.05 for hypoxic mice vs. 
normoxic controls; † P < 0.05 for hypoxic NOD2−/− mice vs. hypoxic NOD2+/+ mice.
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also inhibits insulin-stimulated Akt phosphorylation 
in myotubes [37]. Moreover, we previously observed 
sustained phosphorylation of Akt (Ser473 and Thr308) 
in the presence of platelet-derived growth factor-BB in 
NOD2−/− VSMCs [26]. In the present study, we examined 
the influence of NOD2 on PI3K and Akt signaling to 
determine whether these pathways were responsible for 
NOD2−/− PASMC proliferation under hypoxic conditions. 
Akt phosphorylation increased in NOD2−/− PASMCs after 
hypoxia exposure, and a similar response was observed in 
the ERK signaling pathway (Figure 5C). Moreover, HIF-
1α protein expression, which correlates with sustained 
Akt phosphorylation, was significantly higher in NOD2−/− 
PASMCs than in NOD2+/+ PASMCs under hypoxic 
conditions (Figure 6A), although there were no differences 
in the mRNA levels of Hif-family genes between NOD2−/− 
and NOD2+/+ PASMCs after hypoxic treatment (Figure 
6B-6D). HIF-1α is a key protein in the lung response to 
reduced oxygen availability, and is thought to be involved 
in PH development [5, 8, 15]. Indeed, HIF-1 is necessary 
for smooth muscle hypertrophy, and HIF-1α significantly 
contributes to the remodeling of pulmonary blood vessels 
under chronic hypoxic conditions [8]. The hydroxylation 
of HIF-1α (at proline 564) and the expression of 
PHD2 protein were lower in NOD2−/− PASMCs than in 
NOD2+/+ PASMCs after hypoxia exposure (Figure 6A). 
Interestingly, the levels of VHL, which participates in the 
ubiquitin-dependent degradation of HIF-1α, were greater 
in NOD2−/− PASMCs than in NOD2+/+ PASMCs after 
hypoxia exposure (Figure 6A). 
In conclusion, our findings indicate that NOD2 
is important for the response of PASMCs to hypoxia. 
While we found that Akt activation leads to HIF-1α 
stabilization and PASMC proliferation in NOD2−/− mice, 
future investigations will be required to characterize the 
molecular pathways governing the relationship between 
NOD2 and the Akt signaling pathway. The findings 
presented here have expanded our comprehension of 
the involvement of PRRs in hypoxia-induced PH, and 
demonstrate that NOD2 may be a promising target for 
Figure 5: Absence of NOD2 during hypoxia enhances PASMC proliferation. (A) Total RNA was extracted from NOD2+/+ 
PASMCs exposed to normoxic (N) or hypoxic conditions for the indicated lengths of time. Nod2 mRNA levels were analyzed by quantitative 
real-time RT-PCR, and mouse β-actin was used as a control for normalization. Values are presented as means ± SDs, n = 3. (B) NOD2+/+ 
and NOD2−/− PASMCs were plated and incubated for 72 hours under normoxic (21% O2) or hypoxic (1% O2) conditions. Proliferation was 
then assessed with a BrdU Cell Proliferation Assay Kit. *P < 0.05, increased cell proliferation of NOD2−/− vs. NOD2+/+ PASMCs in response 
to hypoxia. Values are presented as means ± SDs, n = 12. (C) Total protein was extracted from NOD2+/+ and NOD2−/− PASMCs exposed 
to normoxic (N) or hypoxic conditions for the indicated lengths of time. The levels of Akt, phosphorylated Akt (Ser473 and Thr308), total 
ERK and pERK were then assessed by Western blot; β-actin was used as a loading control. Experiments were performed independently at 
least three times.
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therapies to prevent the remodeling of blood vessels in 
pulmonary vascular conditions.
MATERIALS AND METHODS
Animals
NOD2−/− mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME, USA) on a pure C57BL/6 
genetic background, and these mice were bred within our 
animal facility at Harvard Medical School. The Standing 
Committee on Animal Care at Harvard Medical School 
approved all the animal experimentation protocols of this 
study under the guidelines of our approved Institutional 
Animal Care and Use Committee protocol.
Hypoxic exposure and hemodynamic 
measurements
Eight- to ten-week-old NOD2−/− and NOD2+/+ 
littermates were exposed to normobaric hypoxia (10% O2, 
OxyCycler chamber, Biospherix Ltd, Redfield, NY, USA) 
or normoxia (21% O2) for two weeks. After exposure, mice 
were anesthetized with sodium pentobarbital (60 mg/kg), 
and hemodynamic measurements were performed. The 
hearts were excised, and the ventricles were dissected and 
weighed. Right ventricular hypertrophy was calculated as 
the right ventricular weight normalized to the total body 
weight.
Histological analysis and morphometry
Lungs were inflated, harvested, fixed in methyl 
Carnoy’s solution and embedded in paraffin. Sections were 
stained with hematoxylin and eosin and immunostained 
for α-SMA (1:50, Sigma-Aldrich Co. LLC, St Louis, MO, 
USA). Remodeling was quantified as described previously 
[38]. The percent wall thickness was calculated as follows: 
wall thickness (%) = (areaext − areaint) ÷ areaext × 100, 
where areaext represents the external diameter and areaint 
represents the internal diameter of each vessel. PASMC 
hypertrophy was calculated as the vessel wall area divided 
by the number of nuclei per vessel, and reported as the 
area per cell.
Cell culture
Primary PASMCs were isolated from adult (eight- 
to ten-week-old) NOD2−/− and NOD2+/+ mice as described 
[39], with modification. Hypoxia experiments were 
performed in a New Brunswick™ Galaxy® 48 R (1% O2, 
Eppendorf AG, Hamburg, Germany). The NOD2−/− and 
NOD2+/+ PASMCs were grown in Dulbecco’s Modified 
Eagle’s Medium (Life Technologies, Grand Island, 
NY, USA) supplemented with 20% fetal bovine serum, 
penicillin (100 U/mL) and streptomycin (100 μg/mL). 
In all experiments, cells between passages three and 
nine were used. All cells were incubated at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air.
Figure 6: Absence of NOD2 enhances the stability of HIF-1α protein in PASMCs exposed to hypoxic conditions. (A) 
Total protein was extracted from NOD2+/+ and NOD2−/− PASMCs exposed to normoxic (N) or hypoxic conditions for the indicated lengths 
of time. The protein levels of HIF-1α, hydroxylated HIF-1α (Pro564), HIF-1β, HIF-2α, PHD2 and VHL were then assessed by Western 
blot; β-actin was used as a loading control. Experiments were performed at least three independent times. (B–D), Total RNA was extracted 
from NOD2+/+ and NOD2−/− PASMCs exposed to normoxic (N) or hypoxic conditions for the indicated lengths of time. The mRNA levels 
of Hif-1α (B), Hif-1β (C) and Hif-2α (D) were then analyzed by quantitative real-time RT-PCR; mouse β-actin was used as a control for 
normalization. *P < 0.05, upregulation after hypoxia vs. after normoxia (N). NS, not significant. Values are presented as means ± SDs, n = 3.
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Western blot analysis
Protein extracts from lungs exposed to hypoxia 
or normoxia were analyzed by Western blot analysis. 
Cell extracts from 100-mm dishes were harvested with 
radioimmunoprecipitation assay buffer (Tris/Cl, pH 7.6; 
100 mmol/L ethylenediaminetetraacetic acid; 5 mmol/L 
NaCl; 50 mmol/L β-glycerophosphate; 50 mmol/L NaF; 
50 mmol/L Na3VO4; 0.1 mmol/L NP-40; and 0.5% 
sodium deoxycholate) with 1× Complete™ Protease 
Inhibitor Cocktail (Roche Applied Science, Mannheim, 
Germany). Tissue extracts were homogenized with 
radioimmunoprecipitation assay buffer. The protein 
concentrations of the cell lysates were determined with a 
Pierce BCA protein assay kit (Thermo Fisher Scientific, 
Inc., Waltham, MA) and were resolved on 12% sodium 
dodecyl sulfate-polyacrylamide gels. Proteins were 
transferred onto pure polyvinylidene difluoride membranes 
by means of a wet transfer system (GE Healthcare Bio-
Sciences, Pittsburgh, PA, USA). Membranes were blocked 
for 2 hours at room temperature with a 5% nonfat milk 
solution in Tris-buffered saline Tween (TBST) buffer (20 
mM Tris-HCl, pH 7.4; 500 mM NaCl; 0.1% Tween20). 
The blots were then incubated with various antibodies, 
including monoclonal α-SMA (Sigma-Aldrich Co. 
LLC), polyclonal anti-HIF-1α, anti-HIF-2α, anti-HIF-
1β (Bethyl Laboratories, Montgomery, TX, USA), anti-
phospho-Akt (Ser473, Thr308), total Akt (Cell Signaling 
Technology, Inc., Danvers, MA, USA), anti-PHD2, anti-
VHL (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) 
and anti-hydroxy-HIF-1α (Cell Signaling Technology), 
in TBST overnight at room temperature. Equal loading 
was confirmed with an anti-GAPDH (glyceraldehyde 
3-phosphate dehydrogenase) antibody (Santa Cruz 
Biotechnology, Inc.) and anti-β-actin (Sigma-Aldrich Co. 
LLC). The blots were then washed three times in TBST 
and incubated with an anti-rabbit or anti-mouse secondary 
antibody in TBST for 1 hour at room temperature. Finally, 
immunoblots were detected with the SuperSignal® 
West Pico Chemiluminescent Substrate (Thermo Fisher 
Scientific, Inc.) and visualized after exposure to X-ray 
film.
Proliferation assay
The cell proliferation rate at 72 hours was measured 
by BrdU incorporation with the Cell Proliferation ELISA, 
BrdU (colorimetric) kit (Roche Diagnostics, Basel, 
Switzerland) according to the manufacturer’s instructions. 
Quantitative real-time reverse-transcription 
polymerase chain reaction (RT-PCR)
Total RNA was isolated with TRIzol reagent 
(Thermo Fisher Scientific, Inc.), and reverse transcription 
was performed with a SuperScript™ III First-Strand 
Synthesis System (Thermo Fisher Scientific, Inc.). 
Quantitative real-time RT-PCR was conducted with 
iQ SYBR Green Supermix (Bio-Rad Laboratories, 
Inc., Hercules, CA, USA). The primer sequences 
were as follows: mouse Nod1 forward primer 5ʹ- 
GAAGGCACCCCATTGGGTT -3ʹ and reverse primer 5ʹ-
AATCTCTGCATCTTCGGCTGA -3ʹ; Nod2 
forward primer 5ʹ-
CAGGTCTCCGAGAGGGTACTG -3ʹ and reverse 
primer 5ʹ-
GCTACGGATGAGCCAAATGAAG -3ʹ; Tlr2 
forward primer 5ʹ-
GCAAACGCTGTTCTGCTCAG -3ʹ and reverse 
primer 5ʹ-
AGGCGTCTCCCTCTATTGTATT -3ʹ; Tlr4 forward 
primer 5ʹ-
ATGGCATGGCTTACACCACC -3ʹ and reverse 
primer 5ʹ-
GAGGCCAATTTTGTCTCCACA -3ʹ; Hif-1α 
forward primer 5ʹ-
TCATCAGTTGCCACTTCCCCAC -3ʹ and reverse 
primer 5ʹ-
CCGTCATCTGTTAGCACCATCAC -3ʹ; Hif-1β 
forward primer 5ʹ-
TAGACCATCGTTGTGTGGCT -3ʹ and reverse 
primer 5ʹ-
CACCTGCTGAAAGCTGTCTC -3ʹ; Hif-2α 
forward primer 5ʹ-
TAAAGCGGCAGCTGGAGTAT -3ʹ and reverse 
primer 5ʹ-
ACTGGGAGGCATAGCACTGT -3ʹ. 
Amplification of cDNA started with 10 minutes at 
95°C, followed by 40 cycles of 15 seconds at 95°C and 1 
minute at 60°C.
Statistical analysis
Data are shown as the mean ± standard deviation 
(SD). For comparisons between two groups, we used 
Student’s two-tailed unpaired t test. For comparisons 
between more than two groups, and for multiple 
comparisons, we used analysis of variance. Statistically 
significant differences were accepted at P < 0.05.
Abbreviations
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macrophages; ERK: extracellular signal-regulated kinase; 
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